Register entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
Active ingredient (API) manufacture1Finished drug manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| STYRAX PHARMA PRIVATE LIMITED | Plot No. 27B, J N Pharma City, Parawada, Anakapalli, Andhra Pradesh 531021, India (IND) | Active ingredient (API) manufacture, Finished drug manufacture | 3014406503871802852 |
Neighbours
Registered in the same town
12- LAURUS LABS LIMITEDAnakapalli, IND · 4 sites
- Biocon Biologics LimitedAnakapalli, IND · 2 sites
- Granules Pharmaceuticals Inc.Anakapalli, IND · 2 sites
- LAURUS SYNTHESIS PRIVATE LIMITEDAnakapalli, IND · 2 sites
- Viyash Scientific LimitedAnakapalli, IND
- Apitoria Pharma Private LimitedAnakapalli, IND
- Hospira, Inc.Anakapalli, IND
- EUGIA Pharma Specialities LimitedAnakapalli, IND
- NATCO PHARMA LIMITEDAnakapalli, IND
- Ajinomoto OmniChem N.V.Anakapalli, IND
- Apicore US LLCAnakapalli, IND
- Analys Lab Private LimitedAnakapalli, IND
Compare
Comparable companies in India
- Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
- Somerset Therapeutics Private Limited1 site · 187 NDC
- Bionpharma Inc.1 site · 181 NDC
- NURAY CHEMICALS PRIVATE LIMITED1 site · 105 NDC
- Jubilant Biosys Limited1 site · 94 NDC
- Xiromed LLC1 site · 94 NDC
- CAPLIN STERILES LIMITED1 site · 88 NDC
- Maithri Drugs Private Limited1 site · 80 NDC
- MSN Pharmachem Private Limited1 site · 54 NDC
- STHREE CHEMICALS PRIVATE LIMITED1 site · 52 NDC
Enquiry
Common questions
- Is STYRAX PHARMA PRIVATE LIMITED FDA approved?
- STYRAX PHARMA PRIVATE LIMITED holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are STYRAX PHARMA PRIVATE LIMITED's drugs manufactured?
- The FDA register lists Anakapalli. Registered operations: active ingredient (API) manufacture, finished drug manufacture.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.